LYC:ASXLynas Rare Earths Limited Analysis
Data as of 2026-03-14 - not real-time
A$20.70
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Lynas Rare Earths (LYC) is trading at A$20.7, comfortably above its 20‑day (A$17.77) and 50‑day (A$16.20) moving averages and just below the 200‑day average (A$14.09), confirming a strong bullish trend. The RSI sits at 66, below the overbought threshold, while the MACD line (1.22) sits above its signal (0.96), adding further momentum support. Technical analysis shows solid support at A$15.04 and a nearby resistance at A$21.17, suggesting limited upside in the very short term but room to run higher on continued strength. Fundamentally, the stock appears overvalued – a trailing P/E of 259 versus a DCF fair value of only A$4.16, and a downside estimate of –7.2% relative to fair value – yet the company has secured a 12‑year supply agreement with Japanese industry, extending demand certainty to 2038 and providing a price floor that could improve earnings visibility. Revenue growth of 62.7% and a forward P/E of 29.6 indicate that the market is pricing in significant upside from this strategic contract, despite the current lack of free cash flow and a high book‑to‑price multiple (6.2×). The stock’s volatility is elevated at 76% over 30 days, and while beta is slightly negative, the high price swing and sector‑specific supply‑chain risks suggest caution. Overall, the blend of strong technical momentum, a transformative off‑take deal, and an inflated valuation creates a nuanced investment picture.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near technical resistance at A$21.17
- High short‑term volatility (76% 30‑day)
- Recent supply deal providing demand certainty
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Bullish technical indicators (MACD, SMA alignment)
- Long‑term off‑take agreement through 2038
- Strong revenue growth and improving forward earnings outlook
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strategic positioning in critical rare‑earth supply chain
- Secured multi‑year contracts reducing market risk
- Potential for valuation compression as earnings scale
Key Metrics & Analysis
Financial Health
Revenue Growth62.70%
Profit Margin11.50%
P/E Ratio258.8
ROE2.88%
ROA1.40%
Debt/Equity6.32
P/B Ratio6.2
Op. Cash FlowA$129.0M
Free Cash FlowA$-305244992
Technical Analysis
TrendBullish
RSI66.4
SupportA$15.04
ResistanceA$21.17
MA 20A$17.77
MA 50A$16.20
MA 200A$14.09
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueA$4.16
Target PriceA$19.20
Upside/Downside-7.25%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta-0.19
Volatility76.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.